中国医药创新与投资大会

09:00 - 10:25

主持人 Moderator

09:00 - 09:10

09:10 - 09:20

09:20 - 09:40

主题报告1
Keynote Speech 1
发挥一国两制政策优势，打造以香港为核心的医药创新高地
Leveraging policy advantages to build a pharmaceutical innovation center centered around Hong Kong
冯岚, 中国医药创新促进会驻会副会长
FENG Lan, Vice President （Resident) of PhIRDA

09:40 - 10:05

主题报告2
Keynote Speech 2
香港药物和医疗器械监管中心筹备情况介绍
Introduction to Preparation Status of Center for Medical Products Regulation of the Hong Kong Department of Health
林志恒, 香港卫生署药物及医疗器械监管中心筹备办公室总药剂师
LIN Zhiheng, Chief Pharmacist of the Preparatory Office of the Center for Medical Products Regulation of the Hong Kong Department of Health

10:05 - 10:25

主题报告3
Keynote Speech 3
合作共创，携手启航：香港生物科技生态圈，助您扬帆全球
Collaborate to Innovate: Hong Kong's Biotech Ecosystem, Your Global Launchpad
黃秉修, 香港科技园公司行政总裁
Terry WONG, Chief Executive Officer of Hong Kong Science and Technology Parks Corporation

10:25 - 11:10

主持人 Moderator

10:25 - 11:10

Panel嘉宾 Panelist

杜涛, 深圳埃格林医药有限公司董事长
DU Tao, Chairman, Board of Directors，Evergreen Therapeutics
赵孝斌, 海昶生物总裁、创始人
ZHAO Xiaobin, President and Founder of Haichang Biotech
康韦, RDPAC 前执行总裁，粤港澳大湾区医药创新联合会发起人
KANG Wei, Former RDPAC Managing
詹华强, 香港科技大学中药研发中心主任
Karl Wah Keung TSIM, Director of Center for Chinese Medicine R&D, Hong Kong University of Science and Technology
王颖蓓, 香港贸发局江苏代表
Eve WANG, Director, Jiangsu, Hong Kong Trade Development Council
梁卫彬, 上海生物医药基金合伙人、香港生物科技基金总裁
May LIANG, Partner, Shanghai Healthcare Capital; CEO, Hong Kong Biotechnology Fund

11:10 - 12:00

主持人 Moderator

11:10 - 11:35

主题报告4
Keynote Speech 4
如何建立与国际标准接轨的审评体系-以 FDA 为例
How to establish a review system that is in line with international standards - taking FDA as an example
宇文镐, 斯丹姆医药全球注册高级副总裁兼首席商务官
Howard Yuwen, SVP & CBO at SDM Bioservices

11:35 - 12:00

主题报告5
Keynote Speech 5
行稳致远中国创新药走向世界的征程
The Journey of Chinese Innovative Drugs to the World
曹蓓莉, 华领医药技术（上海）有限公司集团运营部及大湾区发展副总裁
Cynthia CAO, VP of Corporate Operation and Great Bay Development, HUA Medicine (Shanghai）Ltd.

香港健康产业论坛